Nicotine Nirvana
Letter data
- Company
- Nicotine Nirvana
- Recipient
- Cliff Loeb | Nicotine Nirvana | United States
- Issue date
- 2021-06-02
- Posted date
- Not available
- FDA office
- Center for Tobacco Products
- Subject
- Not available
- Product
- Tobacco
- CMS ID
- 614671
- Reference number
- RW2101591
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Nicotine Nirvana
MARCS-CMS 614671 —
June 02, 2021
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA UPS and Electronic Mail
Reference #:
RW2101591
Product:
Tobacco
Recipient:
Recipient Name
Cliff Loeb
Nicotine Nirvana
United States
Issuing Office:
Center for Tobacco Products
United States
Dear Cliff Loeb:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses, dated May 10, 2021, May 21, 2021, May 23, 2021, and May 24, 2021, in response to our Warning Letter dated May 7, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.nicotinenirvana.com.
However, our surveillance shows you continue to offer for sale to customers in the United States other tobacco products that may be subject to market authorization requirements. FDA encourages you to discuss with your suppliers the current status of any particular tobacco product’s marketing application or any product’s marketing authorization. For additional information regarding currently marketed tobacco products that a company generally might manufacture, distribute, or sell without risking FDA enforcement, please visit our website
https://www.fda.gov/tobacco-products/market-and-distribute-tobacco-product/deemed-new-tobacco-product-applications-lists?utm_medium=email&utm_source=govdelivery#list%20of%20deemed
.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Sincerely,
/S/
David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
VIA Electronic Mail
cc:
Contact Privacy Inc. Customer 0144274739
nicotinenirvana.com@contactprivacy.com
Tucows, Inc.
domainabuse@tucows.com
Google LLC
google-cloud-compliance@google.com
Content current as of:
06/07/2021
Regulated Product(s)
Tobacco